257 related articles for article (PubMed ID: 15153840)
1. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
Black KL; Ningaraj NS
Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
Ningaraj NS; Rao M; Black KL
Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
[TBL] [Abstract][Full Text] [Related]
3. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
[TBL] [Abstract][Full Text] [Related]
4. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
Ningaraj NS; Rao MK; Black KL
Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
[TBL] [Abstract][Full Text] [Related]
5. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
6. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
8. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
9. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
10. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
[TBL] [Abstract][Full Text] [Related]
11. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.
Black KL; Yin D; Ong JM; Hu J; Konda BM; Wang X; Ko MK; Bayan JA; Sacapano MR; Espinoza A; Irvin DK; Shu Y
Brain Res; 2008 Sep; 1230():290-302. PubMed ID: 18674521
[TBL] [Abstract][Full Text] [Related]
12. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
13. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
14. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
15. Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
Zhang B; Jiang T; Tuo Y; Jin K; Luo Z; Shi W; Mei H; Hu Y; Pang Z; Jiang X
Cancer Lett; 2017 Dec; 410():12-19. PubMed ID: 28939029
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
Xia CY; Zhang Z; Xue YX; Wang P; Liu YH
J Neurooncol; 2009 Aug; 94(1):41-50. PubMed ID: 19234812
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
Drapeau A; Fortin D
Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
Sugita M; Hunt GE; Liu Y; Black KL
Neurol Res; 1998 Sep; 20(6):559-63. PubMed ID: 9713849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
